DeutschNewstral
Article
bizjournals.com on 2018-10-12 20:36
Abiomed says heart pumps not to blame in patient's death
Related news
- FDA clears Abiomed heart pump after concerns over death ratebizjournals.com
- Abiomed investors wary after FDA warns of higher death rate for heart pump recipientsbizjournals.com
- MAbiomed gets heart-pump FDA approval, shares haltedmarketwatch.com
- MAbiomed gets emergency authorization to use heart pump in COVID-19 patientsmarketwatch.com
- Abiomed, Beth Israel test heart pump monitoring system in pilot programbizjournals.com
Johnson & Johnson Co Inc: Johnson & Johnson to buy heart device maker Abiomed in $16.6bn dealFinancial Times- LMassive Growth of Total Artificial Heart Market by 2028 with Top Key Players – Abiomed, Terumo Heart, Inc.liverpoolstudentmedia.com
- KArtificial Organs Market Growing at A CAGR 2020 TO 2027 Top companies focusing ABIOMED, HeartWare, Berlin Heart, Thoratecksusentinel.com
6-year-old heart patient's shooting death rattles St. Louisdecaturdaily.com
FDA Approves New Heart Pump From AbiomedForbes- SA new test could predict how heart attack patients will respond to mechanical pumpssciencedaily.com
Investigation into patient's deathShropshire Star
Heart patient's 'baked Alaska' treatmentBBC
Heart patient's family seeks helpthecitizen.com- Abiomed buys Maryland medical device startupbizjournals.com
- FDA Grants Premarket Approval To AbioMed Heart PumpForbes
J&J Acquires Abiomed for $16.6 Billionjdsupra.com
"I was staring death in the face": Heart transplant patient's thanks to the surgeon who saved his lifeThe Daily Record